CytomX Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Welcome everyone to the 44th annual JPMorgan Healthcare Conference. My name is Anupam Rama. I am one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Rati Pinhei, Joyce Tso, and Priyanka Grover. Our next presenting company is CytomX. I'm presenting on behalf of the company, we have CEO, Sean McCarthy. Sean.
Thank you, Anupam, and thanks to the JPMorgan team for the invitation to present. It really is a privilege to be here. I'm also joined by the squad, Chris Ogden, CFO; Rachel Lester, Chief Business Officer, and I see at the back, Wayne Chu, Chief Medical Officer.
So once again, a real pleasure to be here. Last year 2025 was a super exciting year for CytomX. We don't expect 2026 to be any different. We're working hard on building a highly differentiated pipeline and the theme of what I'll talk about today is unmasking advances in oncology.
Who wants the slide. One second. The clicker
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
